Incretin-based therapy: renal effects
Glucagon like peptide-1 (GLP-1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors are new classes of hypoglycemic agents with numerous pleiotropic effects. The review summarises data about the influence of GLP-1 analogues and DPP-4 inhibitors on structural and functional changes in diabetic ki...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/5c2fe686f9b64d1a9647f4b4cad14b69 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|